|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation, amortization and accretion, net | |||||
| Provision for (recovery of) credit losses | |||||
| Deferred income taxes | |||||
| Gain on sale of held for sale mortgage loans | |||||
| (Gain) loss on sale of investment securities, net | |||||
| Gain on sale of other real estate | |||||
| Write-down of other real estate | |||||
| Gain on sale of premises and equipment | |||||
| Write-down of premises and equipment | |||||
| Restricted stock expense | |||||
| Proceeds from sales of loans held for sale | |||||
| Origination of loans held for sale | |||||
| Cash surrender value of life insurance | |||||
| Change in: | |||||
| Right of use lease asset | |||||
| Other assets | |||||
| Lease liability | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of investment securities available for sale | |||||
| Proceeds from sales, calls and maturities of investment securities available for sale | |||||
| Proceeds from calls and maturities of investment securities available for sale | |||||
| Proceeds from sales of investment securities available for sale | |||||
| Proceeds from paydowns of investment securities available for sale | |||||
| Proceeds from paydowns of other investment securities | |||||
| Purchase of FHLB Stock | |||||
| Net change in loans | |||||
| Purchases of premises and equipment | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from sale of other real estate and repossessions | |||||
| Proceeds from bank owned life insurance | |||||
| Net cash used by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in deposits | |||||
| Net change in securities sold under agreement to repurchase | |||||
| Proceeds from FRB borrowings | |||||
| Repayments of FRB borrowings | |||||
| Restricted stock units exercised | |||||
| Excise tax on stock repurchased | |||||
| Proceeds from Fed Funds Purchased | |||||
| Repayments of Fed Funds Purchased | |||||
| Restricted stock units vested | |||||
| Excise tax on stock repurchased | |||||
| Common stock repurchased | |||||
| Cash dividends paid on common stock | |||||
| Net cash (used) provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at ending of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Income taxes | |||||
| Income taxes, federal | |||||
| Income taxes, state | |||||
| Noncash investing and financing activities: | |||||
| Restricted stock units exercised | |||||
| Change in unrealized gain (loss) on investment securities available for sale, net | |||||
| Restricted stock units issued | |||||
| Excise tax on stock repurchased | |||||
| Change in unrealized loss on investment securities available for sale, net | |||||
| Transfer of loans to other real estate | |||||
| Initial recognition of lease right of use asset and lease liability | |||||
| Allowance for credit losses recorded upon adoption of ASU 326, net of tax | |||||
| DOT settlement receivable | |||||
Loading...